Search Results - "Lorgeot, Valérie"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: Relationship with erythropoietin requirements by Le Meur, Yannick, Lorgeot, Valérie, Comte, Lydie, Szelag, Jean-Christophe, Aldigier, Jean-Claude, Leroux-Robert, Claude, Praloran, Vincent

    Published in American journal of kidney diseases (01-09-2001)
    “…N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) is a physiological inhibitor of hematopoiesis that is maintained at stable levels in normal plasma. Its…”
    Get full text
    Journal Article
  2. 2

    Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection by Le Meur, Yannick, Leprivey-Lorgeot, Valérie, Mons, Sandrine, José, Mattew, Dantal, Jacques, Lemauff, Brigitte, Aldigier, Jean-Claude, Leroux-Robert, Claude, Praloran, Vincent

    Published in Nephrology, dialysis, transplantation (01-07-2004)
    “…Background. Macrophage-colony stimulating factor (M-CSF) is the principal factor for survival of monocytes and macrophages that play an important role in…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Whole blood production of monocytic cytokines (IL-1β, IL-6, TNF-α, sIL-6R, IL-1Ra) in haemodialysed patients by Le Meur, Yannick, Lorgeot, Valérie, Aldigier, Jean-Claude, Wijdenes, John, Leroux-Robert, Claude, Praloran, Vincent

    Published in Nephrology, dialysis, transplantation (01-10-1999)
    “…Background. The production of monocytic cytokines by isolated mononuclear cells after stimulation by phytohaemagglutinin (PHA) and lipopolysaccharide (LPS) is…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Cyclosporin A inhibition of macrophage colony-stimulating factor (M-CSF) production by activated human T lymphocytes by Frétier, Stéphanie, Besse, Arnaud, Delwail, Adriana, Garcia, Martine, Morel, Franck, Leprivey‐Lorgeot, Valérie, Wijdenes, John, Praloran, Vincent, Lecron, Jean‐Claude

    Published in Journal of leukocyte biology (01-02-2002)
    “…M‐CSF is a pleiotropic cytokine involved in the survival, proliferation, and differentiation of cells of the monocyte/macrophagelineage. M‐CSF is produced by…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Plasma leukaemia inhibitory factor, interleukin 6 and soluble interleukin 6 receptor levels during cardiopulmonary bypass with extracorporeal circulation by Denizot, Y, Lorgeot, V, Cornu, E, Nathan, N

    Published in Cytokine (Philadelphia, Pa.) (01-04-1998)
    “…In this study the authors assessed plasma leukaemia inhibitory factor (LIF), interleukin 6 (IL-6) and soluble IL-6 receptor (sIL-6R) concentrations in 28…”
    Get full text
    Journal Article
  10. 10

    PLASMA LEUKAEMIA INHIBITORY FACTOR, INTERLUEKIN 6 AND SOLUBLE INTERLEUKIN 6 RECEPTOR LEVELS DURING CARDIOPULMONARY BYPASS WITH EXTRACORPOREAL CIRCULATION by Denizot, Yves, Lorgeot, Valérie, Cornu, Elisabeth, Nathan, Nathalie

    Published in Cytokine (Philadelphia, Pa.) (01-04-1998)
    “…In this study the authors assessed plasma leukaemia inhibitory factor (LIF), interleukin 6 (IL-6) and soluble IL-6 receptor (sIL-6R) concentrations in 28…”
    Get full text
    Journal Article
  11. 11

    The presence in human serum of a circulating soluble leukemia inhibitory factor receptor (sgp190) and its evolution during pregnancy by Pitard, V, Lorgeot, V, Taupin, J L, Aubard, Y, Praloran, V, Moreau, J F

    Published in European cytokine network (Montrouge) (01-12-1998)
    “…The specific binding of leukemia inhibitory factor (LIF) or oncostatin-M (OSM) to transmembrane gp190 or gp130 leads to their oligomerization which is…”
    Get more information
    Journal Article
  12. 12
  13. 13

    AcSDKP plasma concentrations in patients with solid tumours: comparison of two chemotherapeutic regimens by Comte, Lydie, Lorgeot, Valerie, Volkov, Leonid, Roullet, Bernard, Tubiana, Nicole, Praloran, Vincent

    Published in Cancer letters (15-01-1997)
    “…The tetrapeptide AcSer-Asp-Lys-Pro (AcSDKP) is a physiological inhibitor of the proliferation of haematopoietic stem cells and progenitors. In Ara-C-treated…”
    Get full text
    Journal Article